학술논문
Contemporary use of guideline-based higher potency P2Y12 receptor inhibitor therapy in patients with moderate-to-high risk non-ST-segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross-sectional study
Document Type
Article
Author
Patel, A.; Goodman, S.G.; Yan, A.T.; Bagai, A.; Tan, M.; Suskin, N.; McKelvie, R.; Mathew, A.L.; Lavi, S.; Lutchmedial, S.; Barry, C.; Dehghani, P.; Lavoie, A.J.; Huynh, T.; Philipp, R.; Khan, R.; Radhakrishnan, S.; Madan, M.; Ahmed, S.; Sedlak, T.; Brunner, N.; Fordyce, C.B.; Kim, H.H.; Cieza, T.; Dery, J.-P.; Kassam, S.; Heffernan, M.; Jedrzkiewicz, S.
Source
In: Clinical Cardiology . (Clinical Cardiology, June 2021, 44(6):839-847)
Subject
Language
English
ISSN
19328737
01609289
01609289